Published Date: 17 Mar 2023
Iran: According to a study published in Diabetology and Metabolic Syndrome, triglycerides are elevated in normoglycemic patients.
Read Full NewsFor patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.
Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.
There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.
1.
Study reveals that older women frequently receive an incorrect breast cancer diagnosis.
2.
Immunotherapy Remains Little Used in Head and Neck Cancer
3.
New study reveals racial disparities in breast cancer diagnosis and outcomes in Canada
4.
Older Adults With Advanced Cancer Prioritize Quality of Life
5.
Using AI, one can find cancer risk factors.
1.
Hemophilia B and Gene Therapy: A New Chapter with Etranacogene Dezaparvovec
2.
CEUS in Endometrial Cancer: A Tool for Early Myometrial Infiltration Detection
3.
Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts
4.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
5.
Exploring the Potential of Bendamustine in Cancer Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
3.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
5.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation